Feb 26, 2026
Breaking Free from Opioid Addiction: How Ibogaine Treatment at MindScape Retreat Offers Real Hope
Opioid addiction has reached crisis proportions globally, with conventional treatments offering limited success rates an...
Read Article →How Ibogaine Works
Ibogaine is a psychoactive alkaloid derived from the Tabernanthe iboga plant. It remains investigational, and the current evidence does not establish that it treats addiction, depression, trauma, or neurological conditions.
Researchers are studying its pharmacology and possible clinical uses, but individual experiences and outcomes vary. Ibogaine also carries serious cardiac, neurological, psychiatric, and medication-interaction risks.
A responsible program starts with medical and psychological screening, uses clinician-directed preparation and monitoring, and continues with structured integration. No provider can promise withdrawal relief, craving reduction, or lasting recovery.
Our Protocol
MindScape's clinical program combines Ibogaine HCL with Ibogaine Total Alkaloid (TA) extract. The treating physician determines the formulation and dosing approach after reviewing each patient's medical history, medications, and screening results.
TA contains additional alkaloids from the iboga root. Their clinical effects and any advantage of combining TA with HCL are not established, so we do not claim superior neural repair or recovery outcomes.
Guided 5-MeO-DMT sessions are part of the retreat framework. NAD+ is program-specific and is included only when listed in the accepted program itinerary. These distinct interventions have their own risks and uncertain benefits; neither establishes efficacy for any condition.
Ibogaine treatment is an investigational use of a psychoactive alkaloid with potentially serious risks. It is not approved as a medicine for addiction or mental-health conditions. Screening and monitoring may reduce risk but cannot eliminate it, and no individual outcome is guaranteed.
Compare Care
| Ibogaine | Questions for Any Provider | |
|---|---|---|
| Protocol | HCL + TA extract; guided 5-MeO-DMT; NAD+ only when itinerary-listed | Ask which substances are included and why |
| Medical Staff | Physician and nursing oversight during treatment | Ask who is present and how coverage works |
| Cardiac Screening | EKG, bloodwork, liver panel required | Request screening requirements in writing |
| Integration | 90-day post-retreat support included | Ask for the schedule and provider credentials |
| Accommodation | Private room; bathroom configuration varies by residence | Confirm room, bathroom, meals, and transfers |
| Program Fit | Eligibility and length determined during screening | Ask how length and price are determined |
Review our cardiac screening and safety protocols, including EKG evaluation, liver panels, and contraindication management. Learn how we measure outcomes without unsupported success-rate percentages, and read about our exploratory Parkinson's program.
Areas of Specialization
Your Journey. 4 Steps
Our no-obligation screening process helps the clinical team assess whether a program is appropriate. It includes medical history, cardiac evaluation (EKG), bloodwork, medication review, and psychological assessment. A deposit secures dates only after acceptance.
Before arrival, you have two preparation sessions with a qualified psychologist and receive program-specific guidance. Any medication change must be directed by the treating clinician and coordinated with your prescriber when appropriate.
Your stay length depends on the accepted program: five days for wellness, seven for the core program, and longer for some condition-specific care. Meals, wellness activities, and scheduled excursions accompany the clinical protocol and recovery time.
Every treatment program includes 90 days of aftercare with weekly physician and psychologist video consultations and access to the private alumni community. Integration supports ongoing care but does not guarantee a particular outcome.
All-Inclusive Program
5-day wellness retreat starting price. 7-day core ibogaine program from $8,500. Specialized programs: Parkinson's (14-day), SSRI Discontinuation (10 to 14 day), Opioid (10 to 14 day), and Alcohol (10 to 12 day) are individually priced. Contact us for a personalized assessment and exact program quote.
Program Investment
5-Day Ibogaine Retreat
$7,500
Wellness, personal growth, and introspective exploration. Full all-inclusive stay.
Core Program. 7 Day
$8,500
Screening and program planning for addiction, PTSD, depression, anxiety, trauma, or personal growth. Full all-inclusive stay.
SSRI / Opioid. 10 to 14 Day
$13,500
SSRI discontinuation or opioid addiction. Extended medical supervision and clinician-directed preparation.
Parkinson's. 14 Day
$15,500
Exploratory 14-day program with baseline and follow-up measures and physician oversight.
Each accepted program itinerary lists its included services. Pricing varies by program length and individual medical needs. Payment plans are available upon request. Contact us for a no-obligation consultation and personalized quote.
Primary References
Our protocols align with the primary scientific literature, including the MAPS Ibogaine Investigator's Brochure (July 2026), NIDA's psychedelic & dissociative drugs research, and registered trials on ClinicalTrials.gov. Ibogaine remains investigational; we pair published evidence with measured, real-world outcome tracking.
Clinical FAQs
MindScape Retreat serves patients traveling from the United States and other locations. Cozumel has an international airport, but routes vary by origin and date. Verify current flights and entry requirements before booking. Browse all state pages or select your state below.
Not sure if you're ready? Take our confidential self-assessment, explore our clinical outcomes, read our complete ibogaine treatment guide, or see what ibogaine treatment in Mexico involves: legal status, costs, and how to vet a clinic.
100% Confidential · No Obligation · Response Within 24 Hours
Get our Medical Credentials & Patient Safety Packet
15 pages: our physicians and licenses, cardiac safety standards, emergency protocols, travel guidance, and answers to the questions families ask most.
No spam, ever. Or download it directly without sharing your email.
100% Confidential · No Obligation · Available 7 Days a Week
Every MindScape treatment program includes a guided 5-MeO-DMT (Bufo) ceremony, part of the all-inclusive price, not an add-on.
Precision dosing
Before the main session, we give a short series of low, sub-psychoactive ibogaine TA boosters. Each one is a measurement. Ibogaine and its long-lived metabolite noribogaine both affect the heart's hERG potassium channel, and that effect is dose-dependent, so instead of predicting how you will respond we observe it directly at doses far below a full session. Your main dose is then chosen from your own cardiac response and the margin you have left.
No ibogaine given. 12-lead ECG, electrolytes and liver panel establish the starting point. A baseline outside safe limits stops the programme here.
These are the measurements the protocol is built around. The trace above is a schematic used to explain the method; it is not a recording of a patient, and the values shown are illustrative rather than results.
How the booster protocol works →Explore the clinical evidence behind ibogaine therapy
150+ peer-reviewed studies, active clinical trials, and emerging evidence, curated by our medical team.
Every active ibogaine trial tracked: Stanford MISTIC, DemeRx FDA pathway, UTHealth $50M IMPACT, and more.
Cardiac screening, QTc monitoring, medication review, and emergency protocols. Risk reduction without guaranteed safety.
How we measure outcomes from intake through follow-up, without unsupported success-rate percentages.
Latest Research & News
Feb 26, 2026
Opioid addiction has reached crisis proportions globally, with conventional treatments offering limited success rates an...
Read Article →Feb 25, 2026
Ibogaine has been called a "miracle cure" for addiction by some, dismissed as dangerous pseudoscience by others, and stu...
Read Article →Feb 25, 2026
Opioid addiction has reached crisis levels across North America, with over 100,000 overdose deaths annually in the Unite...
Read Article →Feb 13, 2026
If you're reading this, you're probably in that exhausting, overwhelming place where you know something has to change — ...
Read Article →